Brian Cheng
Analyst
JP Morgan
Equibles does not estimate personal net worth.
About Brian Cheng
Brian Cheng is recorded as Analyst at JP Morgan. Brian Cheng has spoken on 12 earnings calls across 8 companies, most recently for Coherus Oncology, Inc. on November 9, 2026. Those appearances were for Coherus Oncology, Inc. (CHRS), Kymera Therapeutics, Inc. (KYMR), Ptc Therapeutics, Inc. (PTCT), Absci Corp (ABSI), Tg Therapeutics, Inc. (TGTX) and 3 other companies. The companies whose calls Brian Cheng spoke on are classified in the Healthcare sector.
Brian Cheng on recent calls
“Just building on the previous question here, as we think about the guided development app and second-line ESCC for Tecmo and Tori, you know, how should we think about the potential setup of a study?”
“Maybe just on pricing negotiations here in next U.S. regions, you know, can you give us an update on the final pricing agreement that will come soon in Germany and also other countries like France and Spain?”
“Maybe just to start off, we noticed that your indication on your press release is now defined as pattern hair loss. And I think in the prior communication, you have been indicating that the lead indication as androgenetic alopecia.”
“Maybe just to start off on Lactorsi, you know, you guys have got a 10 to 15% quarterly growth here.”
“Just want to touch on the broaden to OLE portion. Can you give us some color on the latest there? how is the rollover rate looking, and are patients allowed to dose adjust across the three doses in the OLE?”
Affiliation history
-
JP Morgan
Analyst
Source not stated
Current
Company network
Absci Corp
ABSI
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-08-11
View calls and events
ASCENTAGE
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-03-26
Recent activity
-
-
-
-
-
-
-
-
-
-
Earnings call
亚盛医药2025年年度业绩发布会
ASCENTAGE
-
-